Pure Biologics (WAR:PUR) Forward Dividend Yield %: 0.00% (As of Jun. 30, 2026)


WAR:PUR Pure Biologics SA WAR:PUR
25 GF Score
Price zł2.24
! 2 Warning Signs
View Full Analysis

What is Pure Biologics Forward Dividend Yield %?

Pure Biologics WAR:PUR -4.68% 25 Forward Dividend Yield % is 0.00% as of Jun. 30, 2026. GuruFocus rates WAR:PUR with a GF Score™ of 25/100. The stock has 2 warning signs investors should review. Among 145 Biotechnology companies, Pure Biologics ranks worse than 689654.48% on this metric.

As of today (2026-06-30), the Forward Annual Dividend Yield of Pure Biologics is 0.00%.

As of today (2026-06-30), the Trailing Annual Dividend Yield of Pure Biologics is 0.00%.

WAR:PUR's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.52
* Ranked among companies with meaningful Forward Dividend Yield % only.

Pure Biologics's Dividends per Share for the three months ended in Mar. 2026 was zł0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Pure Biologics  (WAR:PUR) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Pure Biologics Forward Dividend Yield % Related Terms

WAR:PUR vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, Pure Biologics's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pure Biologics Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pure Biologics's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Pure Biologics's Forward Dividend Yield % falls into.


WAR:PUR
25GF Score
Pure Biologics SA WAR:PUR
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pure Biologics Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Pure Biologics (WAR:PUR) has a Forward Dividend Yield % of 0.00% as of Jun. 30, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Pure Biologics and its competitors. According to the industry distribution chart, Pure Biologics ranks #999999 out of 145 companies in the Biotechnology industry.
Is Pure Biologics' Forward Dividend Yield % too high?
Pure Biologics' current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Pure Biologics ranks #999999 out of 145 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Pure Biologics has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Pure Biologics' Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pure Biologics ranks #999999 out of 145 companies for Forward Dividend Yield %. This places Pure Biologics in the lower half of its industry. The industry median Forward Dividend Yield % is 1.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.52, based on 145 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Pure Biologics and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pure Biologics's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pure Biologics stock overvalued right now?
Pure Biologics (WAR:PUR) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Pure Biologics' overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Pure Biologics (WAR:PUR), the current Forward Dividend Yield % is 0.00% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pure Biologics Business Description

Address ul. Dunska 11, Wroclaw, POL, 54-427
Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.
25GF Score

Get the complete analysis for WAR:PUR

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł2.24
Price